As FDA clears relugolix for uterine fibroids, Myovant, Pfizer gear up to take on AbbVie in commercial rivalry

Pfizer and Myovant have landed the key approval needed to open up the women’s health side of their relugolix franchise, as the FDA clears a …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

As FDA clears re­l­u­golix for uter­ine fi­broids, My­ovant, Pfiz­er gear up to take on Ab­b­Vie in com­mer­cial ri­val­ry